Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
56.5%
% of PPH's 26 holdings also in FTXH
26.0%
% of FTXH's 51 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.2% | 8.1% | 7.2% |
|
ABBVIE INC | 6.3% | 7.0% | 6.3% |
|
MERCK & CO. INC. | 4.8% | 7.1% | 4.8% |
|
PFIZER INC | 4.4% | 7.1% | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% | 7.0% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to FTXH
|
ELI LILLY & CO | 9.9% |
 |
NOVARTIS AG-ADR | 5.8% |
|
CENCORA INC | 5.8% |
|
MCKESSON CORP | 5.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.1% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 5.1% |
 |
SANOFI-AVENTIS-ADR | 5.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.3% |
PPH Underweight Relative to FTXH
|
GILEAD SCIENCES INC | -3.9% |
|
AMGEN INC | -3.8% |
|
UNITED THERAPEUTICS CORP | -3.8% |
|
BIOGEN IDEC INC | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |
|
PFIZER INC | -2.6% |
|
MERCK & CO. INC. | -2.4% |
|
EXELIXIS INC | -2.1% |
|
MEDPACE HOLDINGS, INC. | -1.9% |